Results 11 to 20 of about 218,776 (321)

Left ventricular echocardiographic and histologic changes: Impact of chronic unloading by an implantable ventricular assist device [PDF]

, 1996
Objectives. We studied the effects of chronic left ventricular unloading by a ventricular assist device and assessed left ventricular morphologic and histologic changes.Background.
Harasaki, Hiroaki, James, Karen B., Kottke-Marchant, Kandice, McCarthy, Patrick M., Nakatani, Satoshi, Savage, Robert M., Thomas, James D.   +6 more
core   +1 more source

Practice Issues for Evaluation and Management of the Suicidal Left Ventricular Assist Device Patient [PDF]

, 2020
There is a high prevalence of depression among left ventricular assist device patients, who present with an increased risk of suicidality given access to means via the device either with nonadherence or disconnection.
Chernyak, Yelena, Henderson, Danielle R., Patel, Anahli, Teh, Lisa   +3 more
core   +1 more source

Left Ventricular Assist Device-Related Complications

Journal of Cardiovascular Emergencies, 2020
Left ventricular assist device (LVAD) has emerged as a safe, durable, and revolutionary therapy for end-stage heart failure patients. Despite the appearance of newer-generation devices that have improved patient outcomes, the burden of adverse events ...
Clement Alexandra, Anghel Larisa, Sascău Radu, Stătescu Cristian   +3 more
doaj   +1 more source

Transapical miniaturized ventricular assist device: Design and initial testing [PDF]

, 2011
BackgroundLeft ventricular assist devices are increasingly used to treat patients with advanced and otherwise refractory heart failure as bridge to transplant or destination therapy.
Giridharan, Guruprasad A., Koenig, Steven C., LaRose, Jeff, Sherwood, Leslie, Slaughter, Mark S., Sobieski, Mike A., Tamez, Dan   +6 more
core   +1 more source

The impact of uncorrected mild aortic insufficiency at the time of left ventricular assist device implantation [PDF]

, 2020
OBJECTIVE: The study objective was to investigate the progression of uncorrected mild aortic insufficiency and its impact on survival and functional status after left ventricular assist device implantation.
Damiano, Ralph J, Jr, Fischer, Irene, Itoh, Akinobu, Kotkar, Kunal, Masood, Muhammad F, Moon, Marc R, Nakajima, Tomohiro, Tanaka, Yuki, Wan, Fei   +8 more
core   +2 more sources

Restoration of myocardial β-adrenergic receptor signaling after left ventricular assist device support [PDF]

, 2006
ObjectiveLeft ventricular assist device support for patients with chronic heart failure can significantly improve β-adrenergic receptor signaling, which is likely critical to myocardial recovery.
Akhter, Shahab A., Bulcao, Christian F., Merrill, Walter H., Pandalai, Prakash K.   +3 more
core   +1 more source

Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non–Left Ventricular Assist Device Centers

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Cardiogenic shock (CS) is a complex syndrome associated with high morbidity and mortality. In recent years, many US hospitals have formed multidisciplinary shock teams capable of rapid diagnosis and triage. Because of preexisting collaborative
Joseph I. Wang, Daniel Y. Lu, MHS, Dmitriy N. Feldman, Stephen A. McCullough, Parag Goyal, Maria G. Karas, Irina Sobol, Evelyn M. Horn, Luke K. Kim, Udhay Krishnan   +10 more
doaj   +1 more source

Percutaneous left ventricular assist devices in refractory cardiac arrest: The role of chest compressions

Resuscitation Plus, 2023
Background: Recent studies describe an emerging role for percutaneous left ventricular assist devices such as Impella CP® as rescue therapy for refractory cardiac arrest.
Adam L. Gottula, Brendan M. McCracken, Takahiro Nakashima, Nicholas L. Greer, Traci A. Cramer, Nadia R. Sutton, Kevin R. Ward, Robert W. Neumar, Mohamad Hakam Tiba, Cindy H. Hsu   +9 more
doaj  

Targeted myocardial gene expression in failing hearts by RNA sequencing

Journal of Translational Medicine, 2016
Background Myocardial recovery with left ventricular assist device (LVAD) therapy is highly variable and difficult to predict. Next generation ribonucleic acid (RNA) sequencing is an innovative, rapid, and quantitative approach to gene expression ...
Kajari Dhar, Alexandra M. Moulton, Eric Rome, Fang Qiu, Jeff Kittrell, Eugenia Raichlin, Ronald Zolty, John Y. Um, Michael J. Moulton, Hesham Basma, Daniel R. Anderson, James D. Eudy, Brian D. Lowes   +12 more
doaj   +1 more source

Experience with percutaneous right ventricular support in the early post-left ventricular assist device implantation period (clinical case report and literature reviews)

Вестник трансплантологии и искусственных органов, 2023
Implantable left ventricular assist device (LVAD) is a state-of-the-art treatment for adults and children with end-stage heart failure. The early and late period after LVAD implantation can be severely complicated.
V. N. Poptsov, E. A. Spirina, D. V. Ryabtsev, A. K. Solodovnikova, A. S. Epremian   +4 more
doaj   +1 more source